infecti
bronchiti
viru
ibv
avian
gammacoronaviru
caus
highli
contagi
effect
spread
diseas
respons
substanti
econom
loss
ibv
affect
young
bird
respiratori
renal
infect
high
morbid
mortal
rate
even
secondari
infect
virul
strain
occur
jackwood
also
associ
reproduct
disord
mainli
product
drop
poor
egg
qualiti
outcom
reproduct
tract
infect
cook
et
al
ibv
present
global
distribut
extrem
variabl
variant
classifi
antigen
genet
base
valastro
et
al
share
around
ident
gene
cavanagh
vivid
necess
control
diseas
guid
attent
toward
optim
vaccin
strategi
one
pivot
point
repres
establish
protectotyp
concept
consist
associ
unrel
ibv
vaccin
strain
attempt
widen
confer
protect
cook
et
al
inde
mani
studi
perform
assess
vaccin
kinet
crossprotect
level
promot
differ
vaccin
sever
experiment
trial
administr
rout
time
set
evalu
method
vaccin
quantif
tracheal
swab
jackwood
et
al
ciliostasi
observ
challeng
viru
detect
de
wit
cook
jackwood
et
al
import
adjust
introduc
broiler
vaccin
program
move
second
administr
first
age
previous
vaccin
usual
perform
differ
time
product
cycl
start
prime
dayold
bird
typic
massbas
vaccin
boost
de
wit
cook
rational
behind
approach
better
tracheal
epithelium
recoveri
administr
milder
vaccin
impact
anim
fewer
advers
reaction
de
wit
cook
stronger
immun
respons
van
ginkel
et
al
proven
nevertheless
earlier
second
vaccin
suppli
could
balanc
neg
manag
aspect
irregular
anim
vaccin
often
caus
rollingreact
prevent
vaccin
administr
field
poor
condit
secondari
pathogen
alreadi
present
de
wit
cook
extrem
ibv
strain
variabl
heterogen
differ
part
world
impli
need
accur
evalu
vaccin
protect
everi
new
variant
choic
vaccin
protocol
local
epidemiolog
base
band
et
al
italian
scenario
appear
domin
genotyp
togeth
less
frequent
strain
qx
massachusett
taddei
et
al
strong
emerg
qx
genotyp
commonli
detect
one
attribut
persist
homolog
vaccin
franzo
et
al
chang
epidemiolog
consider
updat
epidemiolog
knowledg
occasion
prompt
tune
vaccin
approach
face
chang
remark
introduct
qx
homolog
vaccin
instead
genotyp
associ
mass
one
even
though
associ
often
report
confer
wide
protect
cook
et
al
broader
strain
rang
effect
protect
especi
toward
qx
strain
terregino
et
al
sarueng
et
al
awad
et
al
anyway
vaccin
strategi
includ
genotyp
still
commonli
appli
unceasingli
evolv
fact
time
sever
vaccin
develop
origin
differ
progenitor
differ
attenu
process
expect
strain
would
display
differ
biolog
featur
could
reflect
efficaci
virul
interact
strain
among
sever
issu
act
poultri
product
avian
metapneumoviru
ampv
emerg
grow
health
problem
also
broiler
farm
catelli
et
al
caus
clinic
sign
secondari
agent
even
detect
pathogen
cecchinato
et
al
itali
vaccin
current
employ
control
diseas
sector
wherea
wide
adopt
among
layer
breeder
achiev
adequ
protect
cecchinato
et
al
mostli
live
inactiv
subtyp
bbase
vaccin
accord
subtyp
b
preval
field
strain
circul
catelli
et
al
cecchinato
et
al
cecchinato
et
al
ampv
infect
identifi
mainli
late
product
stage
cavanagh
et
al
cecchinato
et
al
mani
explan
delay
appear
propos
peculiar
slower
replic
ampv
cook
et
al
share
target
upper
respiratori
tract
epithelium
lead
interfer
ampv
ibv
vaccinefield
strain
replic
cavanagh
et
al
unfortun
comprehens
data
ampv
epidemiolog
differ
ibv
vaccin
pathogen
interact
relev
applic
time
often
lack
anecdot
keep
mind
perform
experiment
trial
aim
evalu
kinet
safeti
recent
commerci
base
vaccin
ie
strain
well
interact
massbas
vaccin
ie
strain
coadminist
one
age
consid
experiment
set
poorli
repres
actual
field
condit
perform
parallel
largescal
epidemiolog
studi
follow
sever
farm
masslik
vaccin
administ
one
age
vaccin
titer
trend
monitor
along
product
cycl
effect
ibv
field
strain
ampv
entri
evalu
two
differ
real
time
revers
transcript
pcr
rtpcr
valid
order
specif
detect
quantifi
vaccin
strain
use
studi
one
assay
aim
detect
masslik
strain
ie
mass
strain
strain
mass
l
ceva
animal
libourn
franc
specif
ibird
ceva
animal
libourn
franc
one
primer
probe
design
variabl
region
align
refer
sequenc
tabl
assay
perform
use
iii
onestep
qrtpcr
kit
carlsbad
ca
usa
nano
instrument
roch
basel
switzerland
assay
valid
titrat
vaccin
mass
strain
strain
strain
account
realtim
rtpcr
detect
viabl
nonviabl
viral
particl
vaccin
well
experiment
field
sampl
realtim
rtpcr
limit
detect
lod
evalu
use
serial
viral
rna
dilut
perform
quadrupl
rang
undilut
vaccin
final
dilut
lod
defin
lowest
viral
amount
detect
least
replic
lod
ibv
strain
mass
strain
specif
assay
assess
test
vaccin
strain
differ
target
one
assay
show
effici
coeffici
determin
higher
experiment
procedur
approv
institut
review
board
anim
research
organismo
preposto
al
benesser
animal
opba
univers
padua
four
group
onedayold
ross
chick
chosen
hatcheri
breeder
anim
individu
mark
hous
separ
room
high
biosecur
measur
twenti
anim
batch
blood
sampl
gather
inform
matern
deriv
antibodi
mda
level
one
trial
group
dayold
bird
vaccin
spray
vaccin
follow
recommend
procedur
differ
vaccin
strain
group
vaccin
strain
group
strain
group
strain
group
strain
vaccin
suspens
titrat
specif
realtim
rtpcr
use
studi
reveal
titer
strain
strain
respect
ten
anim
group
randomli
select
mark
first
sampl
carri
perform
oropharyng
swab
choanal
cleft
pharynx
anim
sampl
maintain
simul
withinflock
vaccin
viru
circul
swab
collect
differ
time
point
h
day
swab
divid
pool
swab
alway
includ
anim
airdri
min
avoid
bacteri
mold
growth
store
process
swab
elut
ml
pb
rna
extract
perform
use
high
pure
rna
isol
kit
roch
basel
switzerland
follow
manufactur
instruct
sampl
underw
masslik
specif
realtim
rtpcr
previous
describ
detect
appli
vaccin
exclus
possibl
contamin
strain
blood
sampl
obtain
onedayold
ross
chick
origin
evalu
mda
level
infecti
bronchiti
viru
antibodi
test
kit
idexx
westbrook
main
usa
use
follow
manufactur
instruct
sampl
sp
absorb
ratio
less
equal
consid
neg
correspond
antibodi
titer
screen
activ
focus
broiler
flock
distribut
northern
itali
sampl
differ
product
cycl
sampl
anim
vaccin
first
life
differ
ibv
vaccin
strain
ie
massbas
vaccin
exclud
strain
follow
protectotyp
concept
sampl
consist
swab
taken
upper
respiratori
tract
sampl
arrang
least
time
point
bird
life
span
per
product
cycl
begin
end
commerci
reason
order
monitor
presenc
vaccin
bird
health
ten
swab
flock
hous
pool
airdri
store
extract
process
previous
describ
sampl
test
ibv
vaccin
amount
quantifi
previous
describ
realtim
rtpcr
addit
diagnost
ibv
field
strain
detect
base
rtpcr
abl
detect
ibv
genotyp
current
circul
itali
perform
least
one
sampl
per
cycl
latest
period
furthermor
whenev
clinic
sign
report
ie
total
amount
test
sampl
relat
sampl
test
independ
anim
age
posit
sampl
sequenc
evalu
presenc
vaccin
strain
genet
stabil
entri
field
strain
briefli
gener
ibv
rtpcr
describ
cavanagh
et
al
cavanagh
et
al
perform
minor
modif
use
iii
onestep
rtpcr
system
taq
dna
polymeras
kit
carlsbad
ca
usa
appli
biosystem
thermal
cycler
appli
biosystem
foster
citi
ca
usa
amplicon
sequenc
use
primer
sequenc
encompass
hypervari
region
gene
use
phylogeneticbas
classif
comparison
refer
strain
valastro
et
al
start
fourth
wk
product
cycl
ampv
detect
expect
cecchinato
et
al
sampl
systemat
analyz
also
ampv
detect
use
multiplex
realtim
rtpcr
cecchinato
et
al
sampl
organ
comprehens
databas
avail
inform
flock
sampl
time
chicken
age
clinic
sign
lab
result
vaccin
detect
titer
sequenc
result
ampv
posit
effect
sampl
age
genotyp
vaccin
viral
titer
evalu
use
robust
analysi
covari
ancova
wilcox
method
compar
trim
mean
group
ie
vaccin
genotyp
viral
titer
differ
time
point
along
covari
ie
sampl
age
trim
level
set
two
thousand
bootstrap
replic
perform
estim
confid
interv
effect
masslik
vaccin
viral
titer
condit
likelihood
ibv
field
strain
detect
assess
use
logist
regress
similar
approach
use
evalu
protect
effect
ibv
vaccin
ampv
infect
presenc
nonrandom
associ
ibv
field
strain
ampv
investig
chisquar
test
analys
perform
use
r
statist
softwar
signific
level
set
pvalu
mda
level
appear
definit
homogen
among
sampl
bird
rang
mean
crosscontamin
detect
among
group
similar
viral
titer
pool
sampl
moment
highlight
group
mean
viral
titer
calcul
pool
sampl
collect
time
point
figur
group
neg
rna
respect
appli
vaccin
h
post
vaccin
everi
sampl
time
group
posit
except
group
appear
neg
rna
pv
group
titer
show
increas
decreas
group
titer
display
peak
reach
higher
titer
masslik
strain
group
present
also
higher
titer
persist
strain
present
differ
behavior
administ
strain
undetect
post
vaccin
subsequ
peak
slight
decreas
second
peak
group
maximum
rna
viral
titer
detect
similar
viral
titer
peak
group
kinet
trend
reveal
strain
tendenc
decreas
associ
masslik
strain
increas
toward
alon
instead
twohundredfortyseven
sampl
analyz
specif
realtim
rtpcr
sampl
posit
strain
masslik
strain
vaccin
titer
distribut
time
reveal
equal
effect
time
genotyp
viral
titer
genotyp
display
posit
skew
curv
viral
titer
rapidli
rise
approxim
first
wk
life
progress
decreas
figur
fact
neg
valu
mass
strain
concentr
within
first
day
howev
genotypespecif
signific
differ
titer
detect
mass
titer
higher
first
half
cycl
quickli
decreas
titer
toward
cycl
end
detect
vaccin
strain
sequenc
well
span
along
product
cycl
presenc
ident
vaccin
sequenc
show
genet
stabil
use
vaccin
opposit
prolong
persist
circul
ibv
gener
rtpcr
sequenc
perform
sampl
result
sequenc
belong
one
administ
vaccin
sampl
qx
genotyp
vaccinelik
strain
differ
five
sampl
classifi
one
defin
recombin
strain
deriv
combin
qx
differ
strain
parent
strain
field
strain
detect
correspond
second
half
product
cycl
particular
vaccin
titer
declin
occasion
high
masslik
vaccin
titer
instead
figur
relationship
vaccin
titer
field
strain
detect
investig
significantli
lower
vaccin
strain
titer
demonstr
field
strain
posit
sampl
compar
neg
one
signific
differ
demonstr
masstyp
vaccin
figur
eightytwo
sampl
test
ampv
ampv
subtyp
b
posit
cycl
ampv
subtyp
b
found
frequent
figur
presenc
recogn
also
togeth
ibv
field
strain
sampl
among
sampl
belong
qx
genotyp
even
though
statist
signific
associ
ampv
ibv
infect
could
proven
interestingli
tendenc
display
lower
ibv
vaccin
titer
emerg
ampv
posit
sampl
figur
although
signific
statist
point
view
huge
ibv
diffus
extrem
genet
variabl
produc
daili
challeng
matter
control
strategi
mainli
reli
aspect
vaccin
immunolog
properti
manageri
aspect
first
one
prompt
research
develop
vaccin
combin
provid
effect
crossprotect
differ
strain
particular
focu
local
circul
one
unfortun
practic
constraint
relat
econom
organiz
choic
farm
manag
led
decreas
vaccin
efficaci
compar
experiment
condit
thu
need
provid
vaccin
abl
effici
spread
field
condit
induc
good
protect
even
presenc
vaccin
coinfect
led
commerci
new
vaccin
strain
implement
new
administr
plan
minim
time
number
intervent
current
studi
replic
dynam
differ
ibv
vaccin
coadminist
one
life
investig
experiment
field
condit
matter
fact
strict
extend
monitor
vaccin
titer
could
allow
verifi
vaccin
administr
efficaci
manageri
point
view
also
biolog
one
experiment
condit
viral
titer
display
common
trend
character
rapid
increas
reach
highest
valu
around
decreas
conclus
trial
except
repres
behavior
strain
administ
combin
strain
appear
show
titer
rise
correspond
expect
decreas
thu
testifi
persist
replic
earli
even
extrem
low
level
probabl
due
prevail
replic
effect
peculiar
behavior
coadministr
vaccineinduc
protect
clear
need
investig
contrari
strain
present
major
titer
alter
either
stand
alon
combin
strain
administr
thu
support
infer
strong
replic
corepl
abil
vaccin
strain
figur
analog
scenario
examin
field
significantli
overlap
result
obtain
similar
experiment
condit
figur
effect
time
genotyp
reveal
vaccin
viral
titer
genotyp
display
posit
skew
curv
viral
titer
rapidli
rise
approxim
first
wk
age
progress
decreas
figur
particularli
neg
result
mostli
locat
begin
cycl
viral
replic
could
homogen
among
anim
viral
spread
could
reach
bird
yet
last
phase
cycl
neg
sampl
frequent
consequ
gener
titer
declin
interestingli
differ
strain
kinet
highlight
certain
higher
replic
capac
masslik
strain
upper
respiratori
tract
first
opposit
longer
persist
strain
partial
mimick
dynam
experiment
condit
administ
alon
display
higher
titer
compar
respect
end
trial
allow
gather
conclus
follow
titer
trend
nevertheless
anoth
studi
et
al
explor
second
half
product
cycl
similarli
vaccin
anim
appear
alway
lower
display
notabl
persist
therefor
observ
pattern
could
attribut
actual
viral
biolog
properti
particular
scenario
separ
discuss
must
reserv
interact
vaccin
even
present
dissimilar
vaccin
trend
quit
overlap
high
viral
titer
frequent
encount
henc
suggest
absenc
competit
genotyp
parallel
coexist
also
administ
day
clearli
conflict
experiment
evid
obviou
interfer
observ
two
main
hypothes
introduc
explain
discrep
first
mass
vaccin
differ
current
use
itali
differ
biolog
properti
viru
could
explain
lower
suscept
competit
addit
field
condit
mass
vaccin
often
provid
hatcheri
provid
upon
arriv
farm
consid
higher
affin
tracheal
receptor
propos
sourc
increas
replic
genotyp
cook
et
al
short
lag
phase
administr
could
enhanc
mass
vaccin
cell
adhes
replic
must
stress
also
experiment
trial
often
poorli
repres
suboptim
condit
found
field
thu
interpret
caution
fact
compar
prolong
vaccin
persist
field
experiment
trial
trend
experiment
condit
could
influenc
viral
titer
small
number
involv
anim
lead
lower
viral
circul
hand
control
environ
could
minim
risk
infect
presenc
stress
immunosuppress
condit
place
premis
unbias
result
pathogen
competit
action
abovement
field
scenario
rais
question
vaccin
viral
attenu
efficaci
immun
respons
appear
insuffici
vaccin
clearanc
within
product
cycl
allow
continu
reinfect
anim
high
environment
infecti
burden
howev
must
clearli
state
prolong
vaccin
circul
could
advantag
increas
vaccin
coverag
grant
protect
effect
ascrib
also
interfer
field
strain
fact
higher
strain
titer
seem
confer
better
protect
field
strain
literatur
report
particular
genotyp
associ
mass
vaccin
administr
could
ensur
strong
protect
qx
strain
terregino
et
al
sarueng
et
al
awad
et
al
preval
itali
detect
one
studi
well
moreov
frequenc
italian
qx
outbreak
correl
vaccin
applic
peak
quit
explain
administr
suspens
franzo
et
al
afterward
clear
effect
viral
competit
emerg
studi
ibv
field
strain
occurr
mainli
second
part
product
cycl
vaccin
titer
decreas
immun
still
effect
continu
stimulu
impos
vaccin
circul
even
sampl
natur
studi
creat
lack
inform
cycl
due
primari
aim
assess
vaccin
adequaci
vaccin
persist
possibl
field
strain
infect
case
clinic
symptom
viral
titer
trend
suggest
similar
decreas
behavior
gap
slight
underestim
ibv
field
strain
ampv
entranc
time
also
could
occur
sinc
first
detect
cycl
find
seem
line
expect
time
especi
ampv
cavanagh
et
al
cecchinato
et
al
matter
fact
anoth
propos
compet
effect
one
ibv
ampv
cavanagh
et
al
cook
et
al
cecchinato
et
al
appear
lighten
sporad
find
ampv
ibv
field
strain
coinfect
last
period
product
cycl
wherea
pauciti
ampv
posit
first
part
cycl
would
enforc
competit
role
sustain
high
ibv
vaccin
titer
tendenc
detect
ampv
presenc
lower
ibv
vaccin
titer
figur
seem
support
certain
interfer
virus
potenti
due
reduct
suscept
cell
number
preactiv
innat
immun
respons
could
hamper
ampv
replic
ampv
field
relev
appear
urgent
nowaday
even
though
clinic
product
impact
pathogen
still
partial
neglect
studi
focuss
ibv
epidemiolog
conclus
drawn
ampv
still
wide
presenc
broiler
promot
accur
survey
moreov
studi
necessari
understand
also
appar
invers
relationship
ibv
vaccin
titer
ampv
infect
actual
due
competit
vaccin
kinet
unconsid
factor
import
simpl
vaccin
kinet
monitor
realtim
rtpcr
appear
evid
titer
kinet
vaccin
persist
suggest
differ
evalu
exert
protect
extend
vaccin
presenc
cycl
end
would
like
propos
competit
role
vaccin
field
strain
entri
rather
classic
immun
assur
quicker
clearanc
vaccin
strain
addit
implic
featur
ampv
ibv
coexist
either
vaccin
field
natur
could
interest
even
like
resourc
conscious
manag
anyway
consider
benefit
studi
account
serolog
immun
protect
evalu
